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Background: Biofeedback (BF) is a self-regulation technique that teaches individuals to alter autonomic balance. In heart failure (HF), decreasing 
sympathetic nervous system (SNS) over-activation with a `-blocker, ACE inhibitor or LVAD, improves clinical status and reverses cellular and 
molecular alterations. We hypothesized that HF patients could use BF to regulate the SNS and produce biological remodeling.
Methods: 20 patients (12 inpatients & 8 outpatients, 17 males & 3 females, mean age 56 +/- 10, mean LVEF 23 +/- 15%, NYHA class III/ IV), all 
listed for cardiac transplant, were studied. BF training included respiratory and temperature feedback. At transplant, explanted hearts were taken to 
the lab, and the inotropic response of LV trabecular muscles to a single dose of isoproterenol was used as an index of SNS recovery.
Results: The average inotropic response of muscles in the BF group (32 muscles from 11 hearts) was compared to those from non-failing (NF; 20 
muscles from 11 hearts), failing (F; 34 muscles from 20 hearts) and LVAD-supported failing human hearts (LVAD; 37 muscles from 17 hearts). Figure 
1 illustrates percent change in developed tension. The BF group showed significant recovery relative to F (p < 0.01), and possibly greater recovery 
than LVAD. 
Conclusions: These preliminary data suggest that BF is associated with positive remodeling of the myocardium in advanced HF patients, providing 
encouraging trends for the design of a randomized trial using BF as an adjunctive therapeutic intervention.
 
